Project Number 5R01AG035055-05 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for PAN-LIPOXYGENASE INHIBITORS FOR CNS DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 8. Cell Death b. Oxidative Stress Researcher and Organization Principal Investigator SCHUBERT, DAVID R Principal Investigator First Name PAMELA Principal Investigator Last Name MAHER Awardee Organization SALK INSTITUTE FOR BIOLOGICAL STUDIES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-07-070: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $375,373 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C Related Resources Repository [AlzPED] A comprehensive multiomics approach toward understanding the relationship between aging and dementia [AlzPED] The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice [AlzPED] A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease
